The intestinal mucosa protects the body from a large reservoir of intraluminal pathogenic bacteria and endotoxins. This mucosal barrier is disrupted by the inflammation and ulceration of inflammatory bowel disease and may permit the absorption of toxic bacterial products.
Abstract
The intestinal mucosa protects the body from a large reservoir of intraluminal pathogenic bacteria and endotoxins. This mucosal barrier is disrupted by the inflammation and ulceration of inflammatory bowel disease and may permit the absorption of toxic bacterial products. Systemic endotoxaemia has been demonstrated in ulcerative colitis and Crohn's disease and correlates with the extent and activity of disease. In this study the efficacy of adsorbents as antiendotoxin agents in a hapten induced rat model of colitis is investigated. Induction of colitis was associated with systemic endotoxaemia. Enteral administration of terra fullonica and kaolin, but not of charcoal, significantly reduced systemic endotoxaemia (terra fullonica 4-2 (1.40) pg/ml; kaolin 5.29 (1.86) pg/ml; charcoal 32*7 pg/ml; water 39*8 (12.6) pg/ml). Data expressed as mean (SE) . With increasing severity of colitis, there was a decreasing ability of adsorbent therapy (terra fullonica) to control systemic endotoxaemia. Enteral administration of adsorbents controls gut derived systemic endotoxaemia in experimental colitis, in animals and may be a useful antiendotoxin treatment in patients with inflammatory bowel disease. (Gut 1993; 34: 51-55) A role for bacteria or their products in the aetiology and pathogenesis of inflammatory bowel disease was suggested over 50 years ago but still remains unproven. In 1937 Shwartzman reported that a local reactivity to bacterial products might be important in the aetiopathogenesis of chronic ulcerative colitis.' Colonic inflammation has been experimentally induced by subserosal injection of bacterial lysate, and by intramucosal injection or intrarectal instillation of Escherichia coli endotoxin.2A Portal and systemic endotoxaemia have been documented in Crohn's disease and ulcerative colitis on many occasions.51-7 Systemic endotoxaemia correlates positively with the presence and extent of intestinal ulceration and with the activity of the disease; and may contribute to the disease activity, the development of toxic megacolon, abnormalities of liver histology and other extraintestinal manifestations of inflammatory bowel disease.7 9 13 18 Attempts have been made to treat systemic endotoxaemia in inflammatory bowel disease. Shwartzman treated 21 patients suffering from ulcerative colitis with a 'phenomenon neutralising anti-colon serum', obtaining good results in 18.' Other successful treatments of systemic endotoxaemia reported in inflammatory bowel disease include polymyxin, haemosorption, and whole gut irrigation with saline and 5-aminosalicylic acid.9 13 15 19 Nolan and Ali recognised the possible contribution of luminal bacterial endotoxins to the activity of inflammatory bowel disease and suggested that luminal endotoxins could be inactivated by an enterally administered non-specific binding agent.20 Ditter et The healthy control group received no additional treatment. The group which initially received 35 mg trinitrobenzenesulphonic acid in ethanol was treated with 300 mg terra fullonica bd for three days.
COLLECTION OF BLOOD
On day 8, the rats were sedated as before and weighed. After cleaning the chest wall with Hibitane (ICI Pharmaceuticals, Wilmslow, UK), blood was collected by closed chest cardiac puncture (to avoid handling of the bowel during collection of blood). Blood for endotoxin estimation was aliquoted into sterile and endotoxin free borosilicate glass tubes containing heparin 20 IU/ml and immediately stored in ice until centrifuged. Blood was also collected for serum lactate and pyruvate determinations (Sigma diagnostics, Sigma Chemical Co, Ltd, Poole, UK), serum albumin and liver function tests.
ASSESSMENT OF COLITIS
A midline laparotomy was made, the terminal ileum and rectum divided and the colon removed. The colon was opened longitudinally and cleaned of faeces by gentle irrigation with water.
Colon macroscopic score The freshly opened colon was pinned out and examined under a Leitz dissecting microscope by two independent observers. The extent of mucosal damage was assessed using a modification of the colon macroscopic scoring system of Wallace et al24 (Table I) . (Table II) . There was no significant difference in the severity of the colonic inflammation between the treatment groups.
Histological examination showed broad based mucosal ulcers with a surface layer of necrotic ulcer slough. Occasional islands of regenerative mucosa were present. The inflammatory infiltrate associated with the ulcers was mixed, consisting of neutrophils, eosinophils, lymphocytes, and plasma cells. Occasional epithelioid granulomata were seen in the ulcer base. The inflammation extended the full thickness of the bowel wall and there was periocolic wrapping of fat. No qualitative differences were observed in the histological appearances of the colon in the treatment groups and no colonic histological abnormality was identified in the saline treated control group. SYSTEMIC 
ENDOTOXAEMIA
Induction of colitis by intracolonic instillation of 25 mg trinitrobenzenesulphonic acid in 30% ethanol was associated with systemic endotoxaemia (healthy controls 4-0 (1-2) pg/ml; disease controls 39-8 (12-6) pg/ml, p<0 05 Mann Whitney).
Enteral administration of kaopectate and terra fullonica over a period of three days produced a significant reduction in systemic endotoxaemia when compared with control therapy (Table III) . Kaopectate and terra fullonica appeared equally effective in their endotoxin-binding activity and eliminated endotoxins from the systemic circula- The Figure shows the systemic endotoxin concentrations plotted against colon macroscopic score for the disease control group (water) and the combined terra fullonica groups (25 and 35 mg trinitrobenzenesulphonic acid/ethanol). With increasing colonic damage there was a greater incidence of endotoxaemia (>10 pg/ml) and the circulating concentrations of endotoxin were higher. With less severe colonic damage, terra fullonica was able to prevent the occurrence of systemic endotoxaemia. As the colonic damage exceeded 6 on the colon macroscopic score, enteral administration of terra fullonica became less effective as an antiendotoxin measure (colon macroscopic score -6, endotoxin conc 4-9 (1-4); colon macroscopic score >6, endotoxin conc 35-9 (13-3): p<0 05 Mann Whitney).
Discussion
It has been suggested that, in inflammatory bowel disease, endotoxins originating from the intestinal flora cross the disrupted intestinal mucosal barrier and enter the portal circulation. 6-7 [8] [9] [10] Colon macroscopic score Endotoxin concentrations after treatment with water and terra fullonica. The enteral administration of kaolin and terra fullonica produced a significant reduction in systemic endotoxaemia compared with the disease control group (water) in this experimental model of colitis. The systemic endotoxin concentrations in these treated groups were not significantly different from healthy animals (4-0 (1-2) pg/ml). The endotoxin concentrations in these animals were below the limit of sensitivity of the assay (8 3 pg/ml) and are considered to be not significant. Charcoal was not found to be effective as an antiendotoxin agent.
These results are similar to those reported by Ditter et 
